Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 3
1959 1
1966 1
1967 1
1968 1
1969 1
1970 1
1971 6
1972 1
1973 3
1974 1
1975 1
1980 2
1981 1
1982 1
1985 2
1986 4
1987 1
1988 3
1989 2
1990 4
1991 2
1992 2
1993 2
1994 3
1995 4
1996 4
1997 9
1998 5
1999 8
2000 6
2001 12
2002 11
2003 9
2004 11
2005 18
2006 19
2007 25
2008 26
2009 33
2010 42
2011 37
2012 43
2013 46
2014 73
2015 101
2016 103
2017 112
2018 105
2019 121
2020 130
2021 158
2022 149
2023 126
2024 153
2025 184
2026 86

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,733 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Gorgoso-Varela
Page 1
Did you mean J. javier gorgojo varela (1 results)?
Molecular mechanisms of antibody somatic hypermutation.
Di Noia JM, Neuberger MS. Di Noia JM, et al. Annu Rev Biochem. 2007;76:1-22. doi: 10.1146/annurev.biochem.76.061705.090740. Annu Rev Biochem. 2007. PMID: 17328676 Review.
Functional antibody genes are assembled by V-D-J joining and then diversified by somatic hypermutation. This hypermutation results from stepwise incorporation of single nucleotide substitutions into the V gene, underpinning much of antibody diversity and affinity maturatio …
Functional antibody genes are assembled by V-D-J joining and then diversified by somatic hypermutation. This hypermutation results fr …
The DEBBRAH trial: Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis.
Vaz Batista M, Pérez-García JM, Garrigós L, García-Sáenz JÁ, Cortez P, Racca F, Blanch S, Ruiz-Borrego M, Fernández-Ortega A, Fernández-Abad M, Iranzo V, Gion M, Martrat G, Alcalá-López D, Pérez-Escuredo J, Sampayo-Cordero M, Llombart-Cussac A, Braga S, Cortés J. Vaz Batista M, et al. Med. 2025 Jan 10;6(1):100502. doi: 10.1016/j.medj.2024.08.001. Epub 2024 Sep 11. Med. 2025. PMID: 39265579 Free article. Clinical Trial.
Translation-coupled mRNA quality control mechanisms.
Monaghan L, Longman D, Cáceres JF. Monaghan L, et al. EMBO J. 2023 Oct 4;42(19):e114378. doi: 10.15252/embj.2023114378. Epub 2023 Aug 22. EMBO J. 2023. PMID: 37605642 Free PMC article. Review.
Auricular embryonal rhabdomyosarcoma.
Arredondo Montero J, Bronte Anaut M, Hernández-Martín S, López-Gutiérrez JC. Arredondo Montero J, et al. World J Pediatr. 2022 May;18(5):358-360. doi: 10.1007/s12519-022-00521-9. Epub 2022 Feb 11. World J Pediatr. 2022. PMID: 35149982 No abstract available.
Dry Eye Disease and Refractive Corrections.
Madrid-Costa D, Wolffsohn JS, Ruiz-Alcocer J, De Gracia P. Madrid-Costa D, et al. J Ophthalmol. 2019 Dec 6;2019:2058618. doi: 10.1155/2019/2058618. eCollection 2019. J Ophthalmol. 2019. PMID: 31885883 Free PMC article. No abstract available.
Ossifying fibromyxoid tumours: A case series.
Pozas J, Thway K, Lindsay D, Fisher C, Smith M, Hayes A, Miah A, Zaidi S, Benson C, Napolitano A, Huang P, Jones RL. Pozas J, et al. Eur J Cancer. 2025 Feb 25;217:115229. doi: 10.1016/j.ejca.2025.115229. Epub 2025 Jan 9. Eur J Cancer. 2025. PMID: 39809106 Free article.
The microbiome and prostate cancer.
Javier-DesLoges J, McKay RR, Swafford AD, Sepich-Poore GD, Knight R, Parsons JK. Javier-DesLoges J, et al. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):159-164. doi: 10.1038/s41391-021-00413-5. Epub 2021 Jul 15. Prostate Cancer Prostatic Dis. 2022. PMID: 34267333 Free PMC article. Review.
Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial.
Gion M, Blancas I, Cortez-Castedo P, Cortés-Salgado A, Marmé F, Blanch S, Morales S, Díaz N, Calvo-Plaza I, Recalde S, Martínez-Bueno A, Ruiz-Borrego M, Llabrés E, Taberner MT, de Laurentiis M, García-Vicente S, Guerrero JA, Boix O, Rodríguez-Morató J, Sampayo-Cordero M, Antonarelli G, Pérez-García JM, Cortés J, Llombart-Cussac A; ATRACTIB Trial Investigators. Gion M, et al. Nat Med. 2025 Aug;31(8):2746-2754. doi: 10.1038/s41591-025-03734-3. Epub 2025 Jun 4. Nat Med. 2025. PMID: 40467896 Free PMC article. Clinical Trial.
What is the Ideal Tidal Volume During One-Lung Ventilation?
Campos JH, Sharma A. Campos JH, et al. J Cardiothorac Vasc Anesth. 2023 Oct;37(10):1993-1995. doi: 10.1053/j.jvca.2023.06.021. Epub 2023 Jun 14. J Cardiothorac Vasc Anesth. 2023. PMID: 37391356 No abstract available.
Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis.
Martín-Gutiérrez A, Loricera J, Narváez J, Aldasoro V, Maiz O, Vela P, Romero-Yuste S, de Miguel E, Galíndez-Agirregoikoa E, Fernández-López JC, Ferraz-Amaro I, Sánchez-Martín J, Moya P, Campos C, López-Gutiérrez F, Castañeda S, Blanco R; Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group. Martín-Gutiérrez A, et al. Eur J Intern Med. 2024 Nov;129:78-86. doi: 10.1016/j.ejim.2024.06.013. Epub 2024 Jun 22. Eur J Intern Med. 2024. PMID: 38908981
1,733 results